Engineering Streamlined Microbial Chassis for Advanced Biomanufacturing. Aspergillus niger is a highly complex filamentous fungus with an extensive metabolic repertoire, often containing redundant pathways and endogenous proteases that can interfere with industrial efficiency. CD Biosynsis provides professional Aspergillus niger Multi-Gene Knockout Strain Construction Services, utilizing state-of-the-art CRISPR-Cas9 and multiplex editing technologies. Our service allows for the simultaneous or sequential deletion of multiple genomic loci to create "clean-background" chassis strains, ensuring higher purity, increased yields, and superior genetic stability for your industrial applications.
Get a Technical QuoteOur multi-gene knockout platform is designed to handle large-scale genomic streamlining, supporting the development of specialized hosts for pharmaceuticals, organic acids, and recombinant proteins. We focus on redirecting cellular energy away from byproduct formation and toward your target molecule.
| Service Tier | Technical Focus | Primary Application | Strategic Value |
|---|---|---|---|
| Clean-Background Chassis | Deletion of 5–10+ endogenous genes | Heterologous pathway hosting | Minimizes substrate competition |
| Metabolic Flux Redirection | Simultaneous knockout of shunts | Citric Acid & organic acid optimization | Blocks byproduct paths to boost yield |
| Protease-Free Host Prep | Multi-locus secreted protease KO | Recombinant enzyme & Antibody prod | Prevents target protein degradation |
| Secondary Metabolite Silencing | Deletion of toxin/pigment BGCs | Food-safety & Industrial fermentation | Enhances biosafety & clarifies broth |
| Pathway Decoupling | KO of regulatory/autophagy genes | Stress-tolerant production strains | Increases fitness during high expression |
1. Pan-Genomic Analysis
2. Multiplex Vector Design
3. Protoplast Editing
4. Stability Testing
Comprehensive bioinformatic evaluation to identify non-essential genes and competitive metabolic nodes within the Aspergillus niger genome.
Technical project feasibility study and Mutual NDA signing.
Designing high-efficiency gRNA arrays and donor DNA templates for seamless multi-locus editing in a single step.
Optimization of Cas9/RNP stoichiometry for high-fidelity multi-site targeting.
Delivery of the CRISPR machinery into fungal protoplasts using optimized chemical or physical delivery methods.
Verification of biallelic knockouts across all target sites via NGS and Sanger sequencing.
Assessment of growth kinetics, morphology, and genetic stability across multiple generations to ensure industrial robustness.
Final delivery of engineered chassis strains and comprehensive characterization dossiers.
We benchmark our genomic streamlining against landmark filamentous fungi research to deliver superior industrial results.
Constructing pathways for drug precursors requires minimal metabolic interference. Technical benchmarks utilized multiplexed CRISPR/Cas9 to delete 10 key metabolic genes (including cat, pyrG, and ku70). This "clean-background" strain achieved high-efficiency bioconversion of nicotine into nicotinic acid, proving the value of multi-gene KO for specialized cell factories.
(Reference: Guo et al., J. Biotechnol., 2022)
To maximize organic acid titers, competitive carbon sinks must be systematically eliminated. Research has demonstrated the simultaneous knockout of 5 genes in TCA cycle branches (such as sdh and maeA). By precisely blocking these bypass routes, citric acid degradation was inhibited, leading to a 25% increase in peak yields at the 5L fermenter scale.
(Reference: Li et al., Metab. Eng., 2023)
Innovative agricultural solutions use A. niger as a carrier for plant-protective agents. By knocking out 3 specific genes related to cell wall synthesis and virulence, researchers engineered a strain capable of functioning as a high-efficiency virus carrier. This system allows for the sustained release of biopesticides to inhibit soil-borne pathogens while remaining ecologically safe.
(Reference: Zhang et al., Plant Biotechnol. J., 2021)
High-level expression of heterologous proteins often triggers cellular stress. Technical projects focused on knocking out 4 negative regulatory genes, including autophagy genes (atg1, atg8). Disruption of these pathways significantly reduced the degradation of secreted antibodies and enzymes, maximizing the recovery of high-value recombinant proteins.
(Reference: Wang et al., Biotechnol. Adv., 2022)
Ready to streamline your industrial host for advanced biomanufacturing?
Contact Us1. How many genes can be knocked out simultaneously in one round?
Our multiplex CRISPR platform can target up to 10 genes in a single transformation cycle. For larger-scale streamlining, we utilize iterative cycles of marker-free editing.
2. Does removing multiple genes affect the industrial fitness of the fungus?
We focus on "non-essential" genes during the bioinformatic design phase. We balance metabolic redirection with cellular health to ensure the final strain remains robust for large-scale fermentation.
3. Is it possible to knockout entire gene clusters at once?
Yes. Beyond single-gene deletions, we specialize in "cluster-level" deletions, removing contiguous genomic regions (up to 100+ kb) that harbor non-essential or toxin-producing pathways.
4. Can you perform multi-gene knockouts in proprietary industrial strains?
Absolutely. We specialize in adapting our CRISPR tools to work in various industrial Aspergillus niger backgrounds, including highly optimized strains for organic acids and enzymes.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.